382 related articles for article (PubMed ID: 12105241)
1. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
[TBL] [Abstract][Full Text] [Related]
2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
Frimat L; Briançon S; Hestin D; Aymard B; Renoult E; Huu TC; Kessler M
Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
[TBL] [Abstract][Full Text] [Related]
4. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
6. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
8. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
15. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
16. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
17. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
[TBL] [Abstract][Full Text] [Related]
18. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Inker LA; Mondal H; Greene T; Masaschi T; Locatelli F; Schena FP; Katafuchi R; Appel GB; Maes BD; Li PK; Praga M; Del Vecchio L; Andrulli S; Manno C; Gutierrez E; Mercer A; Carroll KJ; Schmid CH; Levey AS
Am J Kidney Dis; 2016 Sep; 68(3):392-401. PubMed ID: 27032886
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
20. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
